Literature DB >> 20811707

TC21 promotes cell motility and metastasis by regulating the expression of E-cadherin and N-cadherin in hepatocellular carcinoma.

Hairong Luo1, Xiangfang Hao, Chao Ge, Fangyu Zhao, Miaoxin Zhu, Taoyang Chen, Ming Yao, Xianghuo He, Jinjun Li.   

Abstract

Hepatocellular carcinoma (HCC) is an aggressive type of cancer, and it may be at an advanced stage when it is detected. It has been shown that TC21, a member of the Ras superfamily, is associated with the proliferation, migration and transformation of tumor cells. Previous studies have shown that TC21 is overexpressed in breast, esophageal and oral carcinomas, and that it is closely associated with the early stages of tumorigenesis. In this study, we demonstrate that TC21 overexpression promotes the motility of HCC cells in vitro and intrahepatic metastasis in vivo. Furthermore, experiments examining the effects of both the ectopic expression of TC21 and siRNA treatment in HCC cells showed that TC21 alters the expression of the adhesive molecules E-cadherin and N-cadherin. Our data suggest that TC21 is associated with tumor progression and poor prognosis in HCC.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20811707     DOI: 10.3892/ijo_00000736

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  10 in total

1.  TC21/RRas2 regulates glycoprotein VI-FcRγ-mediated platelet activation and thrombus stability.

Authors:  S Janapati; J Wurtzel; C Dangelmaier; B K Manne; D Bhavanasi; J C Kostyak; S Kim; M Holinstat; S P Kunapuli; L E Goldfinger
Journal:  J Thromb Haemost       Date:  2018-06-08       Impact factor: 5.824

2.  Positive expression of protein chromosome 9 open reading frame 86 (C9orf86) correlated with poor prognosis in non-small cell lung cancer patients.

Authors:  Gui-Lin Peng; Ya-Lan Tao; Qi-Nian Wu; Yu Zhang; Jian-Xing He
Journal:  J Thorac Dis       Date:  2016-07       Impact factor: 2.895

3.  ERK1/2-induced phosphorylation of R-Ras GTPases stimulates their oncogenic potential.

Authors:  C Frémin; J-P Guégan; C Plutoni; J Mahaffey; M R Philips; G Emery; S Meloche
Journal:  Oncogene       Date:  2016-04-18       Impact factor: 9.867

4.  The acute transcriptomic and proteomic response of HC-04 hepatoma cells to hepatocyte growth factor and its implications for Plasmodium falciparum sporozoite invasion.

Authors:  Dingyin Tao; Jonas G King; Rebecca E Tweedell; Philipp J Jost; Justin A Boddey; Rhoel R Dinglasan
Journal:  Mol Cell Proteomics       Date:  2014-02-16       Impact factor: 5.911

5.  The Ras-like protein R-Ras2/TC21 is important for proper mammary gland development.

Authors:  Romain M Larive; Antonio Abad; Clara M Cardaba; Teresa Hernández; Marta Cañamero; Enrique de Álava; Eugenio Santos; Balbino Alarcón; Xosé R Bustelo
Journal:  Mol Biol Cell       Date:  2012-04-25       Impact factor: 4.138

6.  Upregulated expression levels of ADAM10 and EGFR and downregulated expression levels of E-cadherin in hepatocellular carcinomas.

Authors:  Yuan Yue; Yumin Yang; Lei Shi; Zuoren Wang
Journal:  Exp Ther Med       Date:  2013-10-10       Impact factor: 2.447

7.  TDO2 Promotes the EMT of Hepatocellular Carcinoma Through Kyn-AhR Pathway.

Authors:  Lei Li; Tao Wang; Shanbao Li; Zhengqian Chen; Junyi Wu; Wanyue Cao; Qi Wo; Xuebin Qin; Junming Xu
Journal:  Front Oncol       Date:  2021-01-19       Impact factor: 6.244

8.  Predicting chemosensitivity using drug perturbed gene dynamics.

Authors:  Joshua D Mannheimer; Ashok Prasad; Daniel L Gustafson
Journal:  BMC Bioinformatics       Date:  2021-01-07       Impact factor: 3.169

Review 9.  The Role of R-Ras Proteins in Normal and Pathologic Migration and Morphologic Change.

Authors:  Shannon M Weber; Steven L Carroll
Journal:  Am J Pathol       Date:  2021-06-07       Impact factor: 5.770

10.  NLRP3-inflammasome activation is associated with epithelial-mesenchymal transition and progression of colorectal cancer.

Authors:  Yasser Marandi; Shahryar Hashemzade; Heidar Tayebinia; Jamshid Karimi; Alireza Zamani; Iraj Khodadadi
Journal:  Iran J Basic Med Sci       Date:  2021-04       Impact factor: 2.699

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.